ArticleAdvances in therapy2026

Budget Impact of Venetoclax for Newly Diagnosed Patients with Acute Myeloid Leukemia Aged ≥ 75 Years or with Comorbidities Precluding Intensive Chemotherapy in the United States.

Yanqing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.